REAL-WORLD TREATMENT PATTERNS AND OUTCOMES WHEN INITIATING ONCE-DAILY INJECTABLE PEN THERAPY WITH INSULIN GLARGINE OR LIRAGLUTIDE - AN ELECTRONIC MEDICAL RECORDS STUDY

被引：0
|
作者：
Mersey, J. [1 ]
Wei, W. [2 ]
Meyers, J. [3 ]
Wang, C. C. [3 ]
Dalal, M. R. [2 ]
Bromberger, L. A. [1 ]
Levin, P. [4 ]
机构：
[1] MODEL Clin Res, Baltimore, MD USA
[2] Sanofi Aventis US, Bridgewater, NJ USA
[3] RTI Hlth Solut, Res Triangle Pk, NC USA
[4] Bay W Endocrinol Associates, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1648
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A494 / A494
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD PRACTICE PATTERNS, CLINICAL AND ECONOMIC OUTCOMES AMONG US PATIENTS WITH TYPE 2 DIABETES INITIATING ONCE-DAILY INJECTABLE PEN THERAPY WITH INSULIN GLARGINE OR LIRAGLUTIDE
    Raparla, Swetha
    Wei, Wenhui
    Grabner, Michael
    Cuddihy, Robert M.
    Hu, Wenli
    Quimbo, Ralph
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S293 - S293
  • [2] Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes
    Levin, Philip
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Lin, Jay
    Baser, Onur
    [J]. DIABETES, 2012, 61 : A4 - A4
  • [3] The INITIATOR study: real-world treatment patterns and outcomes in patients with type 2 diabetes initiating insulin glargine or liraglutide
    Levin, P. A.
    Wei, W.
    Buysman, E.
    Thayer, S.
    Brekke, L.
    Crown, W. H.
    Grabner, M.
    Ke, X.
    Quimbo, R. A.
    Cziraky, M. J.
    Hu, W.
    Cuddihy, R.
    Chu, J. W.
    [J]. DIABETOLOGIA, 2014, 57 : S53 - S54
  • [4] Real-World Practice Pattern and Outcomes of Patients With Type 2 Diabetes (T2DM) Initiating Injectable Therapy via Insulin Glargine Disposable Pen (GLA-P) or Liraglutide (LIRA)
    Lin, Jay
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    Levin, Philip
    [J]. DIABETES, 2012, 61 : A286 - A286
  • [5] Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
    Saunders, William B.
    Nguyen, Hiep
    Kalsekar, Iftekhar
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2016, 9 : 217 - 223
  • [6] Retrospective Real-World Adherence in Patients With Type 2 Diabetes Initiating Once-Daily Liraglutide 1.8 mg or Twice-Daily Exenatide 10 μg
    Malmenas, Maria
    Bouchard, Jonathan R.
    Langer, Jakob
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (06) : 795 - 807
  • [7] DOES PEN HELP WHEN ELDERLY PATIENTS WITH TYPE-2 DIABETES INITIATE INSULIN? A REAL-WORLD RETROSPECTIVE STUDY OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL
    Miao, R.
    Wei, W.
    Xie, L.
    Baser, O.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A8 - A8
  • [8] Improved adherence to anticoagulant therapy with once-daily regimen: a real-world study in patients with atrial fibrillation in Germany
    Yeh, Y.
    Wang, R.
    Marston, X. L.
    Zimmermann, L.
    Ye, X.
    Gao, X.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 455 - 455
  • [9] A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies
    Wei, Wenhui
    Buysman, Erin
    Grabner, Michael
    Xie, Lin
    Brekke, Lee
    Ke, Xuehua
    Chu, James W.
    Levin, Philip A.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (03): : 375 - 386
  • [10] Real-world clinical and economic outcomes in patients with type 2 diabetes initiating glargine disposable pen vs. insulin detemir disposable pen in a US managed care setting
    Xie, L.
    Wei, W.
    Pan, C.
    Du, J.
    Baser, O.
    [J]. DIABETOLOGIA, 2011, 54 : S415 - S415
12345